Tilray (NASDAQ:TLRY) Shares Up 2.5%

Tilray Inc (NASDAQ:TLRY)’s stock price traded up 2.5% on Tuesday . The stock traded as high as $1.85 and last traded at $1.85. 5,212,722 shares were traded during trading, a decline of 79% from the average session volume of 25,063,506 shares. The stock had previously closed at $1.80.

Tilray Stock Performance

The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The firm’s fifty day moving average price is $1.82 and its 200-day moving average price is $1.87. The firm has a market cap of $1.41 billion, a price-to-earnings ratio of -4.19 and a beta of 2.13.

Tilray (NASDAQ:TLRY) last released its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The company had revenue of $229.90 million during the quarter, compared to analyst estimates of $226.20 million. During the same quarter in the prior year, the company earned ($0.15) EPS. The business’s revenue was up 24.8% on a year-over-year basis. Analysts expect that Tilray Inc will post -0.16 earnings per share for the current year.

Hedge Funds Weigh In On Tilray

Hedge funds have recently modified their holdings of the business. Simplicity Wealth LLC purchased a new stake in Tilray in the 1st quarter valued at $28,000. RPO LLC purchased a new stake in shares of Tilray in the fourth quarter valued at about $28,000. Wellington Wealth Strategies LLC. acquired a new stake in shares of Tilray during the fourth quarter worth about $29,000. HBK Sorce Advisory LLC purchased a new position in shares of Tilray during the first quarter worth about $37,000. Finally, Prospect Financial Services LLC purchased a new position in shares of Tilray during the second quarter worth about $26,000. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.